The need for indwelling vascular access for outpatient parenteral antimicrobial therapy (OPAT) places patients at risk of vascular access complications. The purpose of this study was to describe vascular access complications during OPAT at home, and identify factors associated with their occurrence.
Introduction
The delivery of outpatient parenteral antimicrobial therapy (OPAT) requires the presence of a vascular access device. The choice of device for vascular access varies by the practice setting, the anticipated length of therapy and whether long-term vascular access is required for reasons other than administration of antimicrobial therapy. Having a vascular catheter places patients at risk of vascular access complications.
Different possible sites for OPAT delivery include home, extended care facilities and infusion centres. 1 In a survey conducted by the Emerging Infections Network of the Infectious Diseases Society of America in 2006, the surveyed members reported that 90% of their patients who took OPAT received therapy at home. 2 A major difference between office-or facility-based infusion and home infusion is the person administering the medication. In office-based or facility-based infusions, infusions are done by persons with specific training in the medical field. In contrast, in the USA patients receiving OPAT at home usually administer most of the medication doses themselves. When there is nursing support, the patient and family caregivers usually receive training by a visiting nurse at the initiation of the treatment course, but most subsequent medication doses are administered by the patient or a family caregiver. A visiting nurse typically visits the patient's home once a week for vascular access dressing changes and blood draws for laboratory test monitoring. When there is no nursing support, the patient usually visits a physician's office or infusion centre for vascular access dressing changes and blood draws once or twice a week. The patients and family caregivers are usually not healthcare workers and there could be concerns about the wisdom of allowing them to access vascular access devices and administer medications directly into the bloodstream. This is particularly important because a nationwide survey of practising infectious disease (ID) physicians in the USA found that only 22% of them had systems to track errors, adverse events or 'near misses' associated with OPAT. 3 In studies with reasonable numbers of patients on OPAT, reported vascular access complication rates have varied from 0.5 to 5 complications per 1000 OPAT days, and line infection rates have varied from about 0.2 to 2 per 1000 OPAT days. 4 -11 In a welldescribed cohort in Glasgow, UK, 0.6% of patients had line infections with a cumulative risk of 0.4 per 1000 OPAT days, and 4.1% of patients had other line complications with a cumulative risk of 2.8 per 1000 OPAT days. 12 This was a programme where most patients received their antibiotics in an office setting, the vast majority through peripheral vascular catheters. Among their patients treated via peripherally inserted central catheters (PICCs), midlines and tunnelled central venous catheters, the line infection rate was 0.57 per 1000 OPAT days and the noninfectious complication rate was 3.03 per 1000 OPAT days. 9 In this cohort 36% of patients received their infusions in clinic. Patients receiving OPAT at home are potentially at higher risk of complications. In these patients, the infusions are usually done by people without a medical or nursing education, usually without direct nursing supervision, and the patients are living at home with a vascular catheter for the duration of their treatment. In an OPAT programme at a Veterans Affairs (VA) medical centre, with self-administration at home, 4 of 190 OPAT courses (2%) were complicated by line infections.
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The purpose of this study was to describe the vascular access complications associated with delivery of OPAT at home, and to examine whether the type of vascular access device and other clinical factors were associated with an increased risk of complications.
Methods

Study design and setting
The study was a retrospective cohort study conducted at Cleveland Clinic, a large multispecialty tertiary care referral centre in the USA. Cleveland Clinic has a large OPAT programme that encompasses .3000 OPAT courses a year. All patients treated with OPAT at Cleveland Clinic require evaluation by a Cleveland Clinic ID attending physician before initiation. 13 Every OPAT course requires completion of a structured start-of-care form by the ID physician at the start of the OPAT course. In most cases the same ID physician is responsible for oversight of the OPAT course. The Cleveland Clinic OPAT registry identifies patients through the OPAT start-of-care forms. In our hospital a substantial proportion of the home-bound patients receive their medications through Cleveland Clinic Home Infusion Pharmacy (CCHIP) and a substantial proportion receive nursing support through Cleveland Clinic At Home Nursing (CCAH).
Case ascertainment and inclusion and exclusion criteria
All OPAT courses for patients at least 18 years of age initiated from 1 January 2013 to 1 January 2014 were identified through the Cleveland Clinic OPAT Registry and screened for inclusion in the study. Only OPAT courses that were carried out at home were included. OPAT courses that lasted ,1 day were excluded. Only the first OPAT course per patient was included; all subsequent courses were excluded.
Data sources and data extraction
Sources of data were the Cleveland Clinic OPAT registry and the institution's electronic medical record. Data from the latter were collected via structured electronic queries and manual chart review. Data collected included demographic information, infectious condition being treated, parenteral antimicrobial prescribed, vascular access device and vascular access complications through completion of the OPAT course. Collected data were entered in a relational database (Microsoft w Access). The study was approved by the institution's institutional review board.
Definitions
A vascular access complication was defined as a vascular access complication that triggered an intervention. A vascular catheter infection was defined as a diagnosis of vascular catheter infection based on positive blood cultures or obvious purulence at the catheter site necessitating catheter removal. Vascular catheter occlusion was defined as patient or caregiver inability to infuse the intravenous antibiotic because of lack of flow. Venous thrombosis was defined as a finding of deep or superficial venous thrombosis in the blood vessel harbouring the vascular device or a blood vessel directly proximal to it, on venous duplex imaging. Each vascular access complication was counted only once. For example, if a patient had two interventions for occlusion, the patient was counted as having occlusion as a complication. It was only counted once. Injection drug use (IDU) was defined as use within the preceding 3 months.
Outcomes
The primary outcome was the number of vascular access complications during the OPAT course.
Statistical analysis
Vascular access complication rates were calculated both as percentages of OPAT courses and as rates per 1000 OPAT days. A subset of the OPAT courses with the four most common vascular access devices was examined in a multivariable analysis to determine factors associated with vascular access complications. The distribution of OPAT duration was noted to be skewed to the right. Logarithmic transformation yielded a distribution that was approximately normal. Poisson regression was done using the number of vascular access complications as the outcome variable and vascular access device, log OPAT duration, age, sex, number of antibiotics and IDU as explanatory variables. Patient age, sex, OPAT duration and vascular access device type have previously been shown to be associated with the occurrence of vascular access complications, the latter two holding up on multivariable analysis. 9 We also included the home infusion pharmacy (CCHIP versus other) in our model to adjust for the possibility that events might be more likely to be documented within our electronic medical record if the OPAT was with CCHIP rather than with other pharmacies. The possibility that patients receiving more than one type of intravenous antibiotic might be at greater risk of complications was considered and the number of antibiotics was also included in our model. IDU was felt to be a risk factor for vascular access complications and was also included in our model. Multicollinearity among quantitative variables was looked for using QQ-plot and variance inflation factors, and was not present. The model was checked for overdispersion, which was not present. Recognizing that the primary outcome of number of vascular access complications was a composite outcome whose components did not necessarily have the same pathogenesis, a sensitivity analysis was conducted examining the effect on the incidence rate ratios (IRRs) of significant factors when different definitions of vascular access complications were used, by excluding the complications one at a time from the definition. Statistical analysis was done using R.
14 A level of 0.05 was considered significant.
Results
Between 1 January 2013 and 1 January 2014, of 3161 OPAT courses identified from the Cleveland Clinic OPAT registry, 1949 (62%) were carried out at home. Five courses were excluded because they lasted ,1 day. The remaining 1944 OPAT courses were administered to 1461 patients. The number of OPAT courses per patient ranged from 1 to 9. Only the first OPAT course per patient was included in the study. The 1461 included courses spanned a total of 33579 OPAT days. Shrestha et al.
intravenous antibiotic therapy at the time of discharge from hospital.
Description of vascular access complications
One-hundred-and-thirty-one patients (9%) had one or more vascular access complications, a total of 144 complications, for an overall rate of 4.29 complications per 1000 OPAT days. The most common complication was line occlusion, which occurred in 76 OPAT courses (5%), at a rate of 2.26 events per 1000 OPAT days. Other complications were much less common (Table 2) . Specifically, thrombosis (0.36 events per 1000 OPAT days) and line infection (0.15 events per 1000 OPAT days) each occurred in ,1% of OPAT courses overall. There were only five line infections and 12 thrombotic complications.
Of the five line infections, four occurred in patients with PICCs (0.3% of OPAT courses with PICCs, incidence rate of 0.14 per 1000 OPAT days) and one occurred in a patient with a Hickman catheter (1.1% of OPAT courses with Hickman catheters, incidence rate of 0.72 per 1000 OPAT days). All five line infections were diagnosed based on catheter removal for clinical suspicion of line infection based on local findings. None of them had positive blood cultures. All 12 thromboses occurred in patients with PICCs (1.0% of OPAT courses with PICCs, incidence rate of 0.43 per 1000 OPAT days). Specific vascular access complications are outlined in Table 2 and specific vascular access complications categorized by type of vascular access device are detailed in Table 3 . Table 4 outlines rates of catheter occlusion and thrombosis for antimicrobials received by at least 30 patients. Catheter occlusion rates associated with specific antimicrobial agents ranged from 1.39 to 4.92 per 1000 OPAT days and thrombosis rates ranged from 0 to 1.55 per 1000 OPAT days. The small numbers of events precluded evaluation for significant differences in these rates.
Risk factors for vascular access complications
In a multivariable Poisson regression model, the variables that remained significantly associated with vascular complications are shown in Table 5 . Patients with Hickman catheters had onefifth the number of vascular access complications compared with patients with PICCs (IRR 0.20, 95% CI 0.03 -0.63) and patients with indwelling ports had one-fourth the number of vascular access complications that patients with PICCs did (IRR 0.25, 95% CI 0.04 -0.78), after adjusting for other significant factors. The number of complications with Hohn catheters was not significantly different from those with PICCs. Increasing duration of OPAT was associated with increased risk, and increasing age with decreased risk, of vascular access complications. There were 60% more complications with each log increase in the duration of OPAT, and 1% fewer complications for each additional year of age, when adjusted for other significant factors. Female patients had 62% more complications than did male patients, when adjusted for other significant variables. Patients who injected drugs had .3 times as many vascular access complications as patients without, when adjusted for other significant factors. Having a non-CCHIP as the home infusion pharmacy was associated with significantly fewer vascular access complications. The number of intravenous antibiotics per OPAT course was not associated with the occurrence of vascular access complications.
Sensitivity analysis found that the estimates of the IRR for the identified risk factors were pretty robust to varying definitions of vascular access complications (Figure 1 ). The various definitions 
Effect of vascular access complications on hospital readmission
Of the 1461 patients, 219 (15%) were readmitted within 30 days. Occurrence of vascular access complications was not associated with increased risk of 30 day readmission.
Discussion
In our institution the most commonly employed vascular access device for OPAT is a PICC. Patients with chronic kidney disease usually receive a Hohn catheter, a non-cuffed tunnelled catheter, instead of a PICC. Some patients already have a vascular access device for management of other comorbid conditions. Patients on long-term total parenteral nutrition and some patients receiving cancer chemotherapy often have a Hickman catheter, which is a tunnelled catheter with a cuff for tissue ingrowth. Many patients receiving cancer chemotherapy and some with extremely difficult vascular access have indwelling vascular ports. When present these vascular access devices are usually adequate for OPAT, and additional PICC or Hohn catheter placement for administration of antibiotics is not necessary. The rates of vascular access complications found in our study are towards the lower end of those reported in previous studies of OPAT carried out at home. 5, 8, 10, 11 All the factors associated with increased risk of vascular access complications in our study have biological plausibility or were also identified as risk factors in another study. Type of vascular access device, OPAT duration, younger age and female sex all had at least univariable associations with the occurrence of vascular access complications in a previously conducted study. 9 Additionally, IDU was also identified as a risk factor. In the USA, most of the administration at home is done by the patients or their family members. Outside the USA, the majority of OPAT medication infusion is done by nurses. The findings from this study should be generalizable to patients receiving OPAT at home in most areas where the medications are infused by the patients themselves or by their family members.
Our study has several strengths. All patients in our hospital for whom OPAT is considered are evaluated by the infectious disease service. OPAT is a reasonably safe undertaking, and expected adverse event rates are low. When event rates are small, it is more difficult to detect differences between subgroups. Our large sample size allowed the detection of differences despite small absolute event rates. Our study adjusted for important variables that have previously been shown to be associated with, 9 and those that could reasonably be expected to affect, the rate of vascular access complications. As expected, receiving therapy through our institution's pharmacy was independently associated with documentation of vascular access complications, and this was adjusted for in our model.
The study has its limitations. Being a retrospective study based on data entered in the medical record, this analysis could certainly have underestimated the true rate of events. To minimize this bias, we defined vascular access complications as those that required some clinical intervention. As our ID physicians were the physicians responsible for oversight of the OPAT course, most OPAT complications that required some clinical intervention were probably documented in the medical record. The method of administration (intravenous push, disposable infusion devices or multidose infusion pump) was not available. An earlier study did not find a significant difference in the rates of complications in patients treated at home with intravenous push administration and via minibag infusions. 15 So the lack of method of administration may not be a serious limitation. Patients were serviced by different healthcare entities. The quality of reporting events from all these entities cannot be assumed to be the same, raising the possibility of biased reporting of complications. The entity with the Vascular access complications during OPAT at home 511 JAC pharmacy. We could not include both home infusion pharmacy and home nursing agency because these two variables were highly correlated. Another limitation is that we did not have information on what proportion of infusions were performed by visiting nurses relative to those performed by the patients themselves or family members. Earlier studies have found no significant difference in the rates of complications between self-administration and healthcare personnel administration of OPAT. 8, 9 In conclusion, vascular access complications occur in 9% of patients treated with OPAT at home. Most of these are catheter occlusions. Catheter thrombosis and line infection each occur in ,1% of OPAT courses at home. Patients receiving intravenous antibiotics through Hickman catheters or ports have fewer vascular access complications than those receiving antibiotics through PICCs. Longer OPAT duration, younger age, female sex and IDU are associated with increased risk of vascular access complications.
